Report
Dave Nicoski ...
  • Ross LaDuke
EUR 46.35 For Business Accounts Only

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Underlyings
Antero Resources Corporation

Antero Resources is an oil and natural gas company engaged in the exploration, development and production of natural gas, natural gas liquids (NGLs), and oil properties. The company focuses on unconventional reservoirs, which can generally be characterized as fractured shale formations. The company's drilling operations are focused in the Marcellus Shale and Utica Shale of the Appalachian Basin. The company's industry segments are: the exploration, development, and production of natural gas, NGLs, and oil; marketing of excess firm transportation capacity; and the gathering and processing of natural gas. All of the company's operations are conducted in the United States.

Arch Resources Inc. Class A

Arch Coal is a coal producer. The company's main business is the production of thermal and metallurgical coal from surface and underground mines located throughout the United Staets, for sale to utility, industrial and steel producers both in the United States and around the world. The company's segments are based on two lines of business, metallurgical coal and thermal coal, and may include a number of mine complexes. The company's segments are: the Powder River Basin, containing primary thermal operations in Wyoming; the Metallurgical, containing metallurgical operations in West Virginia; and the Other Thermal, containing supplementary thermal operations in Colorado and Illinois.

Avanos Medical Inc.

Avanos Medical is a medical technology company focused on delivering medical device products with manufacturing facilities in the United States, Mexico, France, Germany and Tunisia. The company provides a portfolio of product offerings focused on chronic care and pain management. Chronic Care product includes: digestive health products such as Mic-Key enteral feeding tubes, and Corpak patient feeding solutions; and respiratory health products such as closed airway suction systems. Pain Management product includes: acute pain products such as On-Q and ambIT surgical pain pumps; and interventional pain solutions, which provides minimally invasive pain relieving therapies.

Biogen Inc.

Biogen is a biopharmaceutical company focused on discovering, developing and delivering therapies for people living with neurological and neurodegenerative diseases as well as related therapeutic adjacencies. The company's main growth areas include multiple sclerosis (MS) and neuroimmunology; Alzheimer's disease and dementia; neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis; movement disorders, including Parkinson's disease; and ophthalmology. The company's marketed products include TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, VUMERITY and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA and FUMADERM for the treatment of severe plaque psoriasis.

Cassava Sciences

Cassava Sciences is a clinical-stage drug development company. The company focuses on developing new product candidates and to guide these through various regulatory and development pathways in preparation for their potential commercialization. The company's clinical-stage biopharmaceutical assets include: PTI-125, which is its product candidate for the treatment of Alzheimer's disease; and PTI-125Dx, which it is developing as a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company owns worldwide rights to PTI-125 and PTI-125Dx, without royalty obligations to any third party.

Centogene

Cortexyme

Cortexyme is a clinical stage biopharmaceutical company focused on developing therapeutics based on data supporting a new theory of the cause of Alzheimer's disease and other degenerative disorders. The company is targeting a specific, infectious pathogen tied to neurodegeneration and chronic inflammation in humans and animal models. The company's proprietary main drug candidate, COR388, is an orally administered, brain-penetrating small molecule gingipain inhibitor.

Evolent Health Inc Class A

Evolent Health is a holding company. Through its subsidiaries, the company is a managed care services firm that supports health systems and physician organizations in their migration toward care and population health management. The company's Services segment provides its customers, who it refers to as partners, with a population health management platform, integrated data and analytics capabilities, claims processing services, including pharmacy benefit management, specialty care management services and health plan administration services. The company's subsidiary, True Health New Mexico, Inc. is a physician-led health plan in New Mexico available via the commercial market for employer-sponsored health coverage.

Goodrich Petroleum

Goodrich Petroleum is an independent oil and natural gas company engaged in the exploration, development and production of oil and natural gas on properties primarily in: Northwest Louisiana and East Texas, which includes the Haynesville Shale Trend: Southwest Mississippi and Southeast Louisiana, which includes the Tuscaloosa Marine Shale Trend; and South Texas, which includes the Eagle Ford Shale Trend. The company owns interests in a number of producing oil and natural gas wells located in several states.

Moderna Inc.

Moderna is creating a new generation of medicines based on messenger RNA to improve the lives of patients. The company uses its platform to identify and develop new mRNA medicines. When the company identifies a combination of platform technologies or programs across mRNA technologies, delivery technologies, and manufacturing processes that can enable shared product features across multiple potential mRNA medicines, it groups those programs as a modality. The company has created six modalities including prohylactic vaccines; cancer vaccines; intratumoral immuno-oncology; localized regenerative therapeuctics; systemic secreted therapeutics; and systemic intracellular therapeutics.

Netlist

Netlist is engaged in providing modular memory subsystems to customers in various industries that require enterprise and storage class memory solutions for business decisions. In addition to its own products, the company resells certain component products that it purchases for the purpose of resale. The company has purchased certain of these products, including NAND flash and dynamic random-access memory products, from Samsung under the terms of the joint development and license agreement. The company utilizes a portfolio of proprietary technologies and design techniques, including planar design, alternative packaging techniques and custom semiconductor logic, to deliver memory subsystems.

Oasis Petroleum, Inc.

Prothena Corp. Plc

Range Resources Corporation

Range Resources is a holding company. Through its subsidiaries, the company is an independent natural gas, natural gas liquids and oil company, engaged in the exploration, development and acquisition of natural gas and oil properties, located in the Appalachian and North Louisiana regions of the United States, primarily in the Marcellus Shale in Pennsylvania and the Lower Cotton Valley formation in Louisiana.

RAPT Therapeutics

RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company is engaged in developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases by utilizing its proprietary drug discovery and development engine. The company's oncology drug candidate, FLX475, inhibits the migration of immunosuppressive regulatory T cells into tumors. The company's inflammation drug candidate, RPT193, inhibits the migration of type 2 T helper cells, into allergically-inflamed tissues.

Sebata Holdings Ltd

Sebata Holdings Limited, formerly MICROmega Holdings Limited, is an integrated holding company focused on the provision of support services, financial services and information technology (IT). The Company's segments include occupational health and safety, labour supply, information technology, financial services and holdings and consolidated. Its support services include occupational health, safety and environmental risk management services and solutions, and integrated human resource solutions, which include recruitment and labor brokering services. Its financial services include specialist intermediary broking service for commercial banks, investment banks, stock brokers and trading entities in the wholesale financial markets. Its IT solutions include converged communications, cloud computing and IT support services; integrated technology solutions and enterprise management solutions for public sector clients, and supply of smart water meters and electronic water-control devices.

SEMLER SCIENTIFC

Southwestern Energy Company

Southwestern Energy is a holding company. Through its subsidiaries, the company is an independent energy company engaged in exploration, development and production activities, including the related marketing of natural gas, oil and natural gas liquids (NGLs) produced in its operations. The company's primary business is the exploration for, and production of, natural gas, oil and NGLs. The company's operations in northeast Pennsylvania are primarily focused on the unconventional natural gas reservoir known as the Marcellus Shale, and its operations in West Virginia and southwest Pennsylvania are focused on the Marcellus Shale, the Utica and the Upper Devonian unconventional natural gas, oil and NGL reservoirs.

Virgin Galactic Holdings (A)

Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports on these Companies
Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch